Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Investor profile

ARCH Venture Partners

Venture capital firm · Founded 1986 · Active in 2026

ARCH Venture Partners is a venture capital firm based in USA, founded in 1986. The page below shows 51 Power Law outcomes from ARCH Venture Partners's portfolio — 45 unicorns ($1B+ valuation) and 0 additional thoroughbreds (companies that crossed $100M+ in revenue without yet reaching $1B+ valuation).

Outcomes are concentrated in Biotech & Life Sciences · Health Tech & Medtech · Food; top portfolio geographies are USA · China · Ireland. ARCH Venture ranks #124 in Global in the 2026 Dealroom Power Law Investor Ranking by cross-stage outcomes.

51 Power Law outcomes Power Law Ranking #124 · Global · 51 Power Law outcomes · Active 2026
Unicorns ↑ 22% 5y
45
Decacorns ↑ 400% 5y
5
Thoroughbreds → 0% 5y
22
01 · Exits

ARCH Venture’s biggest exits.

ARCH Venture portfolio companies worth $1B+ that have IPO’d or been acquired. Each shows its valuation at exit and, in grey, its current value if still public.

IPO · 2004
Entered Series B+Now $38.0B
$1.4B IPO · 2020
Entered Series B+Now $30.5B
IPO · 2000
Entered Series ANow $23.2B
$408M IPO · 2019
Entered Series ANow $11.3B
IPO · 2014
Entered Series ANow $9.0B
$8.0B acquisition · 2020
Entered Series ANow $8.0B
IPO · 2007
Entered Series B+Now $6.9B
IPO · 2009
Entered Series B+Now $5.8B
$4.9B IPO · 2025
Entered Series ANow $4.9B
IPO · 2016
Entered Series ANow $4.7B
$372M IPO · 2018
Entered Series ANow $3.7B
$300M IPO · 2021
Entered Series ANow $3.3B
$2.2B IPO · 2023
Entered Series ANow $249M
$2.2B IPO · 2019
Entered Series B+Now $1.2B
$2.0B IPO · 2026
Entered Series B+Now $2.0B
$180M IPO · 2020
Entered Series ANow $2.0B
$1.8B acquisition · 2024
Entered Series A
IPO · 2013
Entered SeedNow $1.6B
$1.0B IPO · 2017
Entered Series ANow $1.5B
$1.5B acquisition · 2025
Entered Seed
$1.5B IPO · 2019
Entered Series B+Now $1.5B
$1.5B acquisition · 2021
Entered Series A
IPO · 2012
Entered Series B+Now $1.2B
$1.0B IPO · 2021
Entered Series ANow $1.0B
02 · Estimated holdings

ARCH Venture’s selected top holdings.

An estimate of ARCH Venture’s largest live positions — disclosed shareholding × Dealroom’s latest valuation — across 1 companies where ARCH Venture is a named shareholder, worth about $262M in estimated equity value.

#CompanyEst. stakeValuationEst. value
  1. 1 AledadeHealth · Unicorn 7.5% $3.5B $262M

Estimated value = ARCH Venture’s disclosed ownership % × Dealroom’s latest company valuation; direct named stakes only, exited positions excluded. Figures are indicative, not reported marks. See the underlying cap tables on Dealroom →

03 · Portfolio analysis

The 51 ARCH Venture Power Law outcomes ($100M+ revenue or $1B+ valuation).

Snapshot of where the outcomes are concentrated by country, sector, and stage entered.

By countryCount
  1. USA47
  2. China2
  3. Ireland1
  4. France1
By sectorCount
  1. Biotech & Life Sciences46
  2. Health Tech & Medtech3
  3. Food1
  4. Other B2B Software1
By stage enteredCount
  1. Series B+18
  2. Series A27
  3. Seed3
04 · Portfolio market map

ARCH Venture's 51 Power Law outcomes.

Stage entered
Outcome tier
Region
Group by
51 of 51 Power Law outcomes
05 · Power Law comparison

How does ARCH Venture stack up?

ARCH Venture in orange, your selection in blue and other colours. Pick from the global roster of 35 peer investors — scope by startup location or hit "Find similar shapes" to auto-pick the three closest. The funnel matrix mirrors the spider chart on the ranking page; the line chart shows each firm's share of unicorns minted in the selected startup location — peaks reveal vintage years.

Compare against

Share of new unicorns per year

% of global unicorns minted that year, year by year · hover the chart to see which unicorns

Stage focus

Companies by entry stage and outcome tier

Sector focus

Companies per investor across the 10 highest-volume sectors
Source: Dealroom Power Law dataset. Investors shown are the 2026 Power Law top 35 by combined entry-to-outcome score, drawn from the overview and locations_data sheets. Funnel-matrix axes rescale per-axis using the maximum among the currently selected investors, so the polygons always fill the chart for shape comparison.
06 · Portfolio founders

Where ARCH Venture's portfolio founders come from — and where they studied.

163 founders across the 51 Power Law outcomes — split by country of origin, university attended, and the company they worked at before founding. Massachusetts Institute of Technology and Moderna Therapeutics are the deepest single pipelines.

LocationCount
United States104
Lebanon7
Canada5
United Kingdom5
India5
China5
Ireland4
Germany4
Lithuania3
Netherlands3
+5 more →
UniversityCount
Massachusetts Institute of Technology11
The University of Chicago6
McGill University4
University of Cambridge3
University of Illinois Urbana Champaign3
University of Washington3
University of Michigan3
Yale University School of Medicine3
University of Alberta2
Utrecht University2
+59 more →
Origin companyCount
Moderna Therapeutics3
Tessera Therapeutics3
Apple2
Microsoft2
Juno Therapeutics2
Illumina2
GRAIL2
Beam Therapeutics2
Editas Medicine2
Leetchi2
+38 more →
Origin = country a founder is born in or grew up in (founders may have multiple origins; counts include all entries). University = highest-listed degree. Origin company = a previous employer where the founder was tagged before starting their current company.

Market sentiment

What the market is saying about ARCH Venture Partners

An AI-synthesized read of the highest-engagement posts about ARCH Venture on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

In the news

Latest news about ARCH Venture Partners

Recent press, funding announcements, and portfolio moves mentioning ARCH Venture — pulled live from Dealroom's news feed.

See all news

Want the full picture on ARCH Venture Partners?

The Dealroom platform tracks every round, every co-investor, and every portfolio company in real time — across 25,000+ investors and 3M+ companies globally.